Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals
1993 ◽
Vol 109
(1-2)
◽
pp. 3-6
◽
2016 ◽
Vol 53
(1)
◽
pp. xv-xvi
2008 ◽
Vol 14
(18)
◽
pp. 5678-5684
◽
2008 ◽
Vol 14
(18)
◽
pp. 5692-5699
◽
Keyword(s):
2016 ◽
Vol 13
(s2)
◽
pp. S95-S103
◽
2008 ◽
Vol 14
(18)
◽
pp. 5700-5706
◽